HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL is excited to highlight its participation in IMCAS 2023, a significant event that provided our team with a valuable opportunity to connect with our customers and esteemed partners.
During the event, we had the privilege of sharing insights into our innovative platform and discussing our ambitious future plans. This interaction not only reinforced our relationships but also allowed us to forge new collaborations that will play a role in shaping our company’s journey.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.